MDM2-positive atypical lipomatous neoplasm/well-differentiated liposarcoma versus spindle cell lipoma of the orbit

Ophthalmic Plast Reconstr Surg. 2010 Nov-Dec;26(6):413-5. doi: 10.1097/IOP.0b013e3181cd62eb.

Abstract

Purpose: To distinguish, in a 36-year-old man, an atypical lipomatous neoplasm/well-differentiated liposarcoma from a spindle cell lipoma in a recurrent orbital tumor.

Methods: Clinical, radiographic, and histopathologic evaluations coupled with immunohistochemical studies for CD34, factor XIII, bcl-2, S-100, muscle-specific actin, Ki-67, and MDM2.

Results: MDM2 gene amplification was discovered in the CD34 tumor cells. An average Ki-67 proliferation index of 28% was ascertained for the original and recurrent lesions. These findings established the diagnosis of a well-differentiated liposarcoma with lipoma-like and spindle cell features and ruled out a spindle cell lipoma.

Conclusion: Well-differentiated liposarcoma is a slow growing, infiltrative, and nonmetastasizing neoplasm that is microscopically and diagnostically challenging. It can be reliably separated from a benign spindle cell or an atypical lipoma by using the markers MDM2 and Ki-67.

Publication types

  • Case Reports

MeSH terms

  • Actins / analysis
  • Adult
  • Antigens, CD34 / analysis
  • Biomarkers, Tumor / analysis*
  • Factor XIII / analysis
  • Humans
  • Ki-67 Antigen / analysis
  • Lipoma / chemistry
  • Lipoma / diagnosis*
  • Lipoma / diagnostic imaging
  • Liposarcoma / chemistry
  • Liposarcoma / diagnosis*
  • Liposarcoma / diagnostic imaging
  • Magnetic Resonance Imaging
  • Male
  • Orbital Neoplasms / chemistry
  • Orbital Neoplasms / diagnosis*
  • Orbital Neoplasms / diagnostic imaging
  • Proto-Oncogene Proteins c-bcl-2 / analysis
  • Proto-Oncogene Proteins c-mdm2 / analysis*
  • S100 Proteins / analysis
  • Tomography, X-Ray Computed

Substances

  • Actins
  • Antigens, CD34
  • Biomarkers, Tumor
  • Ki-67 Antigen
  • Proto-Oncogene Proteins c-bcl-2
  • S100 Proteins
  • Factor XIII
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2